SCHEMBL30970211

SCHEMBL30970211

Cc1nccn1Cc1ccc(-c2cc(CC(C)C)sc2S(N)(=O)=O)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 20/20 0.53
CYP3A4 P08684 1/20 0.40
AGTR1 P30556 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26124846 0.91 AGTR2 (0.52) AGTR2CYP3A4
SCHEMBL30970221 0.90 CYP2D6 (0.48) AGTR2CYP3A4
SCHEMBL25248505 0.89 AGTR2 (0.51) AGTR2CYP3A4
SCHEMBL29437911 0.89 AGTR2 (0.51) AGTR2CYP3A4
SCHEMBL30970220 0.88 AGTR2 (0.56) AGTR2CYP3A4AGTR1
SCHEMBL23121085 0.88 AGTR2 (0.65) AGTR2AGTR1
SCHEMBL30645018 0.86 AGTR2 (0.49) AGTR2CYP3A4
SCHEMBL26127110 0.86 AGTR2 (0.49) AGTR2CYP3A4
SCHEMBL30970213 0.86 AGTR2 (0.53) AGTR2CYP3A4
SCHEMBL30970217 0.86 AGTR2 (0.53) AGTR2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4648850-A1 SELECTIVE ANGIOTENSIN II COMPOUNDS Vicore Pharma AB (SE) 2025-11-19 EP disclosed
WO-2024149712-A1 SELECTIVE ANGIOTENSIN II COMPOUNDS VICORE PHARMA AB (SE) 2024-07-18 WO disclosed